Saturday, July 11, 2026

pharma · Metastatic Breast Cancer · Talaromycosis

Duke University

Duke University trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
2
Drugs
5
Patents
0
Intelligence · Clinical Trials

Duke University clinical trials

Registry index of 2 ClinicalTrials.gov studies linked to Duke University programs — each row shows trial ID, program name, phase, status, and indication.

Duke University trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

2 updates

Latest clinical program signals indexed for Duke University.

  1. Liposomal Amphotericin B (LAmB) — Phase 3

    Clinical update
  2. Abraxane — Phase 2

    Clinical update

Trial registry

2 studies